AN EFFECTIVENESS AND SAFETY STUDY OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (IRD) IN PARTICIPANTS WITH MULTIPLE MYELOMA PREVIOUSLY RECEIVING A BORTEZOMIB-BASED TRIPLET INDUCTION REGIMEN (TOURMALINE MM-6):